Effects of Dance and Tai Chi on Balance and Wellbeing on Healthy Adults
Launched by UNIVERSITY OF WOLVERHAMPTON · Feb 27, 2024
Trial Information
Current as of July 27, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how dance and Tai Chi can improve balance and overall wellbeing in healthy adults aged 18 to 59. Over eight weeks, participants will be divided into three groups: one group will take dance classes, another will practice Tai Chi, and the third group will be on a waiting list with no specific activities. The main focus of the study is to see how these activities affect mental wellbeing, while also looking at changes in physical function and mood.
To be eligible for this trial, participants must be healthy adults within the specified age range and should not have any chronic medical conditions or recent injuries that could interfere with physical activities. Importantly, people who are already taking regular dance or Tai Chi classes or those with ongoing illnesses will not be able to participate. If you join the study, you can expect to learn either dance or Tai Chi while contributing to important research that could help understand the benefits of these activities for mental and physical health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. healthy male and female adults of any ethnicity aged from 18 to 59
- • 2. no chronic medical conditions and
- • 3. no physical injuries in the past 3 months that could potentially affect physical activities
- Exclusion Criteria:
- • 1. participants who are currently engaging in regular dance or Tai Chi classes
- • 2. currently has a chronic disease or acute illness
About University Of Wolverhampton
The University of Wolverhampton is a leading educational institution dedicated to advancing research and innovation across various disciplines, including health and clinical sciences. With a strong emphasis on collaboration and community engagement, the university actively participates in clinical trials aimed at improving patient outcomes and healthcare practices. Its commitment to ethical research, combined with a robust framework for conducting trials, positions the University of Wolverhampton as a significant contributor to the advancement of medical knowledge and the development of effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Walsall, West Midlands, United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported